Sei Investments CO Maxcyte, Inc. Transaction History

Sei Investments CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$3.94 - $5.38 $10,850 - $14,816	-2,754 Reduced 3.75%	70,706 $296,000
Q4 2023 Feb 14, 2024	SELL	$2.6 - $5.24 $3,868 - $7,797	-1,488 Reduced 1.99%	73,460 $345,000
Q3 2023 Nov 14, 2023	SELL	$3.02 - $5.1 $58,086 - $98,093	-19,234 Reduced 20.42%	74,948 $233,000
Q2 2023 Aug 11, 2023	SELL	$3.69 - $5.35 $20,841 - $30,216	-5,648 Reduced 5.66%	94,182 $432,000
Q1 2023 May 12, 2023	BUY	$4.03 - $5.89 $323,419 - $472,690	80,253 Added 409.94%	99,830 $494,000
Q4 2022 Feb 10, 2023	SELL	$4.92 - $7.4 $335,248 - $504,236	-68,140 Reduced 77.68%	19,577 $106,000
Q3 2022 Nov 14, 2022	SELL	$4.52 - $6.51 $7,064 - $10,175	-1,563 Reduced 1.75%	87,717 $570,000
Q2 2022 Aug 15, 2022	BUY	$3.59 - $6.81 $320,515 - $607,996	89,280 New	89,280 $422,000

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $426M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.